Efficacy and Safety of Microencapsulated Benzoyl Peroxide 3% and Microencapsulated Tretinoin 0.1% (E-Bpo/E-Atra) in Acne Vulgaris: Results from Two Randomized Controlled Clinical Trials
Main Article Content
Keywords
Acne Vulgaris, Benzoyl Peroxide, Topical Retinoid, Safety, Efficacy
Abstract
Abstract not available.
References
1. Zaenglein AL, et al. J Am Acad Dermatol. 2016;74:945-973 e933
2. Walsh TR, et al. Lancet Infect Dis.2016;16:e23-33;
3. Matin T, Goodman MB. 2019. Available from http://www.ncbi.nlm.nih.gov/books/ NBK537220/
4. Kawashima M, et al. JDermatol. 2017;44:1212-1218
5. Kircik LH. J Drugs Dermatol. 2013;12:s73-76
6. Sagransky M, et al. Expert Opin Pharmacother.2009;10:2555-2562;
7. Fakhouri T, et al. J Drugs Dermatol. 2009;8:657-661
8. Martin B, et al. Br J Dermatol. 1998;139 (Suppl 52):8-11
9. Patel VB, et al. Drug Dev Ind Pharm. 2001;27:863-869
10. Quigley JW, Bucks DA. J Am Acad Dermatol. 1998;38:S5-10
11. Brand B, et al. J Am Acad Dermatol. 2003;49 (3Suppl):S227-232.
2. Walsh TR, et al. Lancet Infect Dis.2016;16:e23-33;
3. Matin T, Goodman MB. 2019. Available from http://www.ncbi.nlm.nih.gov/books/ NBK537220/
4. Kawashima M, et al. JDermatol. 2017;44:1212-1218
5. Kircik LH. J Drugs Dermatol. 2013;12:s73-76
6. Sagransky M, et al. Expert Opin Pharmacother.2009;10:2555-2562;
7. Fakhouri T, et al. J Drugs Dermatol. 2009;8:657-661
8. Martin B, et al. Br J Dermatol. 1998;139 (Suppl 52):8-11
9. Patel VB, et al. Drug Dev Ind Pharm. 2001;27:863-869
10. Quigley JW, Bucks DA. J Am Acad Dermatol. 1998;38:S5-10
11. Brand B, et al. J Am Acad Dermatol. 2003;49 (3Suppl):S227-232.